At the mRNA level, we saw upregulation of the HCC markers Afp, Gpc3 (glypican-3)38, Spp1 (osteopontin)39 and Birc5 (survivin)40 in all DEN-treated mice compared to controls. The gene discussed is GPC3; the disease is hepatocellular carcinoma.